This new 3-country report from the author is available by country, market segment, section, or individual test.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.
The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.
Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Business Opportunities and Strategic Recommendations
Specific new product development opportunities with potentially significant market appeal during the next five years.
Design criteria for new products.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Tests
Sales and market shares of major cancer diagnostic product suppliers in major countries by individual test.
Five-year test volume and sales forecasts for major cancer diagnostic assays.
Instrumentation Review
Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
Assessment of latest technologies and their potential applications for cancer diagnostic testing.
Review of competing/complementing technologies.
Companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Competitive Strategies
Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
Get Help With Cleaning
After a year of dealing with the outbreak, cleanliness has become a serious issue and with good reason. Meeting standards of cleanliness to minimize risk isn’t just a matter of staying in business, it’s a matter of keeping people safe and healthy. With that in mind, it might be a good idea to get some extra help with your cleaning. For certain services and businesses, a...
Get Help With Cleaning
After a year of dealing with the outbreak, cleanliness has become a serious issue and with good reason. Meeting standards of cleanliness to minimize risk isn’t just a matter of staying in business, it’s a matter of keeping people safe an...
With only 5% of the population fully vaccinated against COVID-19 as of February 17, and vaccination being an essential component for full reopening of the economy, WalletHub today released its report on the Safest States During COVID-19, along with accompanying vid...
With February being National Children’s Dental Health Month and the CDC reporting no COVID-19 transmissions in a clinical dental setting, the personal-finance website WalletHub today released its report on 2021's States with the Best & Worst Dental Health, as...